Peripheral muscle dysfunction in idiopathic pulmonary arterial hypertension
暂无分享,去创建一个
F. Maltais | S. Provencher | D. Saey | S. Martel | V. Mainguy | P. Gagnon | M. Simon
[1] A. Torbicki,et al. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. , 2008, Journal of the American College of Cardiology.
[2] K. Webb,et al. Organization of metabolic pathways in vastus lateralis of patients with chronic obstructive pulmonary disease. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.
[3] M. Humbert,et al. Changes in exercise haemodynamics during treatment in pulmonary arterial hypertension , 2008, European Respiratory Journal.
[4] J. Douketis,et al. The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). , 2008, Chest.
[5] H. Katus,et al. Skeletal muscle dysfunction in patients with idiopathic pulmonary arterial hypertension. , 2007, Respiratory medicine.
[6] P. Wagner,et al. Endothelin-1-mediated vasoconstriction at rest and during dynamic exercise in healthy humans. , 2007, American journal of physiology. Heart and circulatory physiology.
[7] F. Herth,et al. Exercise and Respiratory Training Improve Exercise Capacity and Quality of Life in Patients With Severe Chronic Pulmonary Hypertension , 2006, Circulation.
[8] J. Loscalzo,et al. Pulmonary arterial hypertension. , 2004, Annals of medicine.
[9] D. Meads,et al. The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR): A Measure of Health-Related Quality of Life and Quality of Life for Patients with Pulmonary Hypertension , 2006, Quality of Life Research.
[10] H. Katus,et al. Respiratory muscle dysfunction in idiopathic pulmonary arterial hypertension , 2005, European Respiratory Journal.
[11] R. Naeije. Breathing more with weaker respiratory muscles in pulmonary arterial hypertension , 2005, European Respiratory Journal.
[12] R. Naeije,et al. Increased Sympathetic Nerve Activity in Pulmonary Artery Hypertension , 2004, Circulation.
[13] M. Polkey,et al. Quadriceps strength assessed by magnetic stimulation of the femoral nerve in normal subjects , 2004, Clinical physiology and functional imaging.
[14] J. Hirsh,et al. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.
[15] F. Maltais,et al. Peripheral muscle endurance and the oxidative profile of the quadriceps in patients with COPD , 2004, Thorax.
[16] D. Mccrory,et al. Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. , 2004, Chest.
[17] F. Maltais,et al. Contractile leg fatigue after cycle exercise: a factor limiting exercise in patients with chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.
[18] M. Humbert,et al. Inflammation in pulmonary arterial hypertension , 2003, European Respiratory Journal.
[19] R. Ross,et al. ATS/ACCP statement on cardiopulmonary exercise testing. , 2003, American journal of respiratory and critical care medicine.
[20] I. Piña,et al. Exercise and heart failure: A statement from the American Heart Association Committee on exercise, rehabilitation, and prevention. , 2003, Circulation.
[21] D. Chemla,et al. Haemodynamic evaluation of pulmonary hypertension , 2002, European Respiratory Journal.
[22] P. Kao,et al. High prevalence of autoimmune thyroid disease in pulmonary arterial hypertension. , 2002, Chest.
[23] M. Matsuda,et al. Involvement of Endogenous Endothelin-1 in Exercise-Induced Redistribution of Tissue Blood Flow: An Endothelin Receptor Antagonist Reduces the Redistribution , 2002, Circulation.
[24] M. Mador,et al. Comparison of potentiated and unpotentiated twitches as an index of muscle fatigue , 2002, Muscle & nerve.
[25] ATS statement: guidelines for the six-minute walk test. , 2002, American journal of respiratory and critical care medicine.
[26] R. Speich,et al. Clinical classification of pulmonary hypertension. , 2004, Journal of the American College of Cardiology.
[27] F. Maltais,et al. Peripheral muscle wasting in chronic obstructive pulmonary disease. Clinical relevance and mechanisms. , 2001, American journal of respiratory and critical care medicine.
[28] J. E. Hansen,et al. Exercise Pathophysiology in Patients With Primary Pulmonary Hypertension , 2001, Circulation.
[29] F. Maltais,et al. Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD , 2000, Thorax.
[30] M. Polkey,et al. Quadriceps strength and fatigue assessed by magnetic stimulation of the femoral nerve in man , 1995, Muscle & nerve.
[31] E H Bergofsky,et al. Survival in Patients with Primary Pulmonary Hypertension: Results from a National Prospective Registry , 1991 .
[32] J. Fridén,et al. How to calculate human muscle fibre areas in biopsy samples--methodological considerations. , 1984, Acta physiologica Scandinavica.
[33] K. Mabuchi,et al. Actomyosin ATPase. II. Fiber typing by histochemical ATPase reaction , 1980, Muscle & nerve.
[34] J. Bergström. Percutaneous Needle Biopsy of Skeletal Muscle in Physiological and Clinical Research , 1975 .
[35] P. Andersen,et al. Capillary density in skeletal muscle of man. , 1975, Acta physiologica Scandinavica.
[36] J. Bergstrom. Percutaneous needle biopsy of skeletal muscle in physiological and clinical research. , 1975, Scandinavian journal of clinical and laboratory investigation.